Core Insights - Chinese innovative pharmaceutical companies are increasingly engaging in large-scale business development (BD) transactions, signaling a shift from being "followers" to "participants" and "contributors" in the global pharmaceutical landscape [1][6][10] Group 1: Major BD Transactions - Recently, major BD deals have been reported, including a $60 billion deal by 3SBio and a $53.3 billion strategic collaboration between CSPC and AstraZeneca [1][3] - In January, Innovent Biologics licensed its DLL3 ADC to Roche for $800 million upfront and potential milestone payments up to $1 billion [1][2] - In March, HAPO announced a global strategic partnership with AstraZeneca, receiving $175 million upfront and potential milestone payments up to $4.4 billion [2][3] Group 2: Market Trends and Growth - The total value of BD transactions for Chinese innovative drugs is projected to reach $52.3 billion in 2024, with an upfront payment of $4.1 billion, both setting historical records [3][5] - As of May 27, 2024, the total value of BD transactions for Chinese innovative drugs has already reached $45.5 billion, indicating a strong growth trajectory [3][5] Group 3: Policy and Regulatory Support - The Chinese government has implemented a series of reforms to support innovative drug development, including a significant reduction in drug approval times from an average of 3 years to 60 days [6][7] - The recent proposal to further reduce clinical trial approval times to 30 working days aims to enhance the efficiency of drug development [7][8] Group 4: Competitive Advantages - Chinese innovative drugs are becoming increasingly attractive to multinational pharmaceutical companies due to their cost-effectiveness and faster development timelines [10][11] - The average R&D cost for innovative drugs in China is significantly lower than in the U.S., with estimates suggesting costs are 20% to 30% of those in the U.S. [11][12] Group 5: Industry Positioning - China has emerged as a leader in the global pharmaceutical innovation landscape, with the number of innovative drugs entering clinical trials surpassing that of the U.S. [8][9] - The number of innovative drugs approved in China has increased dramatically, from 3 in 2015 to 39 in 2024, marking a twelvefold increase [7][8]

Core Viewpoint - The Hong Kong Dividend Low Volatility ETF (520550) has shown remarkable performance in the current market, characterized by a combination of low volatility and high dividends, making it an attractive investment option during uncertain market conditions [1][5]. Performance Summary - The ETF has reached 34 new highs this year, with continuous net inflows and increasing scale, indicating strong investor interest [1]. - From the beginning of the year to June 20, 2025, the ETF has outperformed both the dividend index and the CSI 300, achieving a growth rate of 15.47% [5]. Dividend Mechanism - The ETF features a monthly dividend assessment mechanism, allowing for up to 12 dividend distributions per year, which is appealing for income-focused investors [3]. - The second cash dividend distribution occurred on June 20, 2025, with the next opportunity for new investors to receive dividends not available until July [4]. Key Factors for Performance 1. **High Dividend Yield and Low Valuation**: The current dividend yield of the Hang Seng High Dividend Low Volatility Index is 7.82%, with some constituent stocks yielding over 8%, significantly higher than the A-share dividend index and the 10-year government bond yield. The index's price-to-earnings ratio is 7.07, and the price-to-book ratio is 0.61, indicating many stocks are trading below their book value, providing a strong margin of safety [7]. 2. **Policy and Capital Support**: The government has mandated that insurance funds increase their equity market investment ratio starting in 2025, favoring undervalued, high-dividend assets. This has led to a significant increase in net purchases of Hong Kong stocks, surpassing 80% of the total for 2024, providing solid support for dividend stocks [8]. 3. **Product Advantages**: The ETF has the lowest fee rate in the market, with a total expense ratio of only 0.2%. It offers monthly dividends for stable cash flow and supports T+0 trading, allowing for flexible adjustments based on market fluctuations. The index's mechanism limits individual stock weight to 5%, enhancing diversification and avoiding "high dividend traps" [9]. Market Behavior - In times of market uncertainty, funds tend to flow back into high dividend sectors. While some Hong Kong tech stocks have yet to recover to pre-tariff highs, the Hong Kong Dividend Low Volatility ETF has already set new highs, illustrating the adage: "In a bull market, one profits from stock prices; in a bear market, from dividends; and in a volatile market, from dividends" [10].

文 | 银行螺丝钉 （转载请注明出处） 今天大盘低开高走，截止到收盘，大盘整体微涨，还在5星。 周末地区冲突加剧，不过今天A股港股市场相对坚挺。 沪深300等大盘股略微上涨，中小盘股上涨较多。 1. 最近看到一些平台上，投资者在讨论，啥时候站上3400点，为啥站上3400点就那么难？ 这个3400说的是上证指数。 这勾起了螺丝钉的一些回忆。 像咱们估值表开始定期更新的时候，当时市场热议的，是啥时候上证指数站上2000点。 因为当时市场在大熊市，指数几次上攻2000点，又跌回到一千多点，站上2000点很难。 后来在2015年中小盘牛市、2016-2017年价值股牛市后，上证指数站上2000点，就没跌回去到1000多点了。 到了前几年，市场又讨论，上证指数啥时候站上3000点。 几次上证指数站上3000点，又跌回到2000多点。 后来市场上涨，上证指数这大半年在3000多点，向着3400点进攻。 2. 上证指数是从多少点开始的呢？ 从1990年前后，100点左右开始的。 指数点数=估值*盈利。 盈利长期上涨，带动上证指数点数提升。 可能再过几年，讨论的是什么时候登上4000点、5000点。 3. 不过上证指数，只 ...

证券研究报告｜基金配置周报 2025 年 06 月 23 日 政策支持高端医疗器械创新发展，可关注哪些机会？ 【20250616-20250622】 | ◼ | 市场回顾：上周权益市场主要指数集体收跌，北证 50 跌幅最 | | | --- | --- | --- | | | 大，下跌 2.55%；债券市场长短端利率集体下行，一年期国债 | 大同证券研究中心 | | | 下行 4.50BP，期限利差有所走阔，长短端 AAA 信用利差均有所 | 分析师：杨素婷 | | | 收窄；基金市场中偏股基金指数和二级债基指数均周度收跌， | 执业证书编号： | | | 中长期纯债和短期纯债基金指数周度飘红；申万 31 个行业跌 | S0770524020002 | | | 多涨少，仅银行、通信和电子收涨。 | 邮箱：yangst@dtsbc.com.cn | | ◼ | 权益类产品配置策略： | | | ➢ | 事件驱动策略：（1）国家药监局部署支持高端医疗器械创新发 | | | | 展工作，可关注：南方医药保健 A(000452)、鹏华品牌传承 | 地址：山西太原长治路 111 号山 | | | (000431)和信澳 ...

Market Overview - A-shares opened lower but closed higher, with the Shanghai Composite Index at 3381.58 points, up 0.65%, and a trading volume of 442.8 billion yuan. The Shenzhen Component Index closed at 10048.39 points, up 0.43%, with a trading volume of 679.8 billion yuan [1] - The computer, defense, and coal sectors led the gains, while food and beverage, and home appliances sectors lagged [1] Geopolitical Events - On June 21, U.S. President Trump announced the completion of attacks on Iranian nuclear facilities, prompting calls from Iranian officials for missile strikes on U.S. naval vessels and the blockade of the Strait of Hormuz [1] - U.S. Vice President Pence stated that any disruption of shipping in the Strait would be "suicidal" for Iran, as the Iranian economy heavily relies on this route [1] - The market reacted calmly to these developments, with gold and oil prices initially rising but later declining, indicating a low perceived risk of the Strait being closed [1] A-share Market Sentiment - Short-term risk appetite in A-shares has decreased, with coal and banking sectors leading the gains again [2] - Port data has shown early signs of decline, and the macroeconomic focus is shifting from external demand to domestic policy [2] - Increased geopolitical tensions in the Middle East pose additional risks, but such event-driven trades are considered difficult and short-lived [2] Bond Market Outlook - The continued easing of monetary policy and weakening domestic data may lead to better performance in the bond market [3] - The current bond market rally is supported by a more favorable monetary easing environment compared to previous rounds [3] - Major banks are actively buying short-term government bonds, leading to a decline in short-term interest rates and a steepening yield curve [3] Financial Sector Performance - The Financial ETF (510230) rose by 1.35%, driven primarily by the banking sector [4] - The banking sector has shown a broad-based increase, with various types of banks reaching new highs [4] Banking Sector Analysis - The trading logic of the banking sector has shifted significantly, moving from a strong positive correlation with macroeconomic fundamentals to a strong negative correlation with the ten-year government bond yield [7] - The market has begun to downplay the impact of bank fundamentals, particularly net interest margins, due to the perceived dividend stability of bank stocks [8] - Despite a narrowing net interest margin, banks have improved asset quality, which supports higher valuations [10] Investment Recommendations - Investors are advised to focus on financial ETFs (510230) and consider buying on dips, given the current market conditions and the banking sector's performance [10]

摘要 1、今天，A股三大指数集体收涨，有超4400只个股上涨，新能源、银行板块涨幅居前。 2、市值第一的工商银行六连阳，再创历史新高， 这些基金经理重仓！银行还有多大上涨空间？ 3、A股何时走出调整？从历史的波动规律看未来机会！ 真话白话说财经，理财不说违心话 --这是第1371 篇白话财经- - 今天，A股终于迎来反弹，三大指数集体收涨，有超4400只个股上涨。 （图片来源：东方财富APP，统计截至2025/6/23，不作投资推荐） 两市成交额超1.12万亿，盘面上，能源金属、港口、计算机、银行保险等板块涨幅居前。 分析人士认为， 下半年，A股市场有望呈现出震荡向上的行情特征。中长期视角下，一轮全新的供给侧改革正在酝酿。 银行板块大涨，这些基金经理重仓 要说今年哪个行业表现最好，你以为是科技？消费？都不是！ 答案是银行！从申万一级行业年内表现来看，银行上涨12.73%位居首位。 今天，银行板块再度上涨，A股市值一哥工商银行走出了六连阳，股价再创历史新高， 最新总市值为2.68万亿元。 （图片来源：东方财富APP，统计截至2025/6/23，不作投资推荐） 在重仓工商银行的基金中，除了上证50、沪深300等指 ...

Core Viewpoint - The article discusses the contrasting views of major investment banks regarding the future of gold prices, with Citigroup warning of a potential end to the gold bull market, while Goldman Sachs maintains a bullish target of $4,000 per ounce [1] Group 1: Investment Bank Perspectives - Citigroup issues a warning that the gold bull market may be coming to an end due to potential selling pressure from the funds [1] - Goldman Sachs supports a target price of $4,000 for gold, suggesting that central bank demand could offset the effects of a "peace dividend" [1] Group 2: Market Signals - There is a significant risk signal indicated by the dollar short positions reaching a 19-year peak, suggesting a potential for a historic short squeeze in the market [1]

量化金融研究丨深度报告 [Table_Title] 广发中证智选高股息策略 ETF（159207）：聚焦 高息资产，把握低风险下高确定性 %% %% %% %% research.95579.com 1 丨证券研究报告丨 报告要点 [Table_Summary] 中证智选高股息策略指数选取 50 只连续分红且现金分红预案股息率较高的上市公司证券作为 指数样本，以反映股息率较高上市公司证券的整体表现。该指数由中证指数公司发布，指数代 码：932305.CSI，指数简称：智选高股息。智选高股息指数在全区间的年化收益率达到 13.37% （2005 年 12 月 31 日至 2025 年 6 月 11 日），超越中证 500（10.63%）、沪深 300（7.92%） 等宽基指数以及中证红利指数（10.09%）等高股息策略指数。广发中证智选高股息策略 ETF （159207）采用指数化投资策略，紧密跟踪标的指数，追求跟踪偏离度和跟踪误差最小化。 分析师及联系人 [Table_Author] SAC：S0490524080006 SAC：S0490513030001 邓元哲 覃川桃 SFC：BUT353 [Table ...

研究报告 Research Report 23 Jun 2025 珍酒李渡 ZJLD (6979 HK) 珍酒李渡跟踪报告：立足长远，前瞻布局 Take a Long-term Perspective and Plan Ahead [Table_yemei1] 观点聚焦 Investment Focus [Table_Info] 维持优于大市 Maintain OUTPERFORM 评级 优于大市 OUTPERFORM 现价 HK$6.16 目标价 HK$8.80 HTI ESG 0.9-1.3-3.0 E-S-G: 0-5, (Please refer to the Appendix for ESG comments) 市值 HK$20.87bn / US$2.66bn 日交易额 (3 个月均值) US$5.85mn 发行股票数目 3,389mn 自由流通股 (%) 31% 1 年股价最高最低值 HK$10.34-HK$5.71 注：现价 HK$6.16 为 2025 年 06 月 20 日收盘价 资料来源： Factset 1mth 3mth 12mth 绝对值 -8.7% -16.8% -23.1% 绝 ...

Investment Rating - The report maintains a recommendation for H-shares over A-shares, emphasizing the potential of Hong Kong dividend assets [1]. Core Insights - The report highlights that H-shares have outperformed A-shares, with significant gains in key dividend stocks during June 2025. The top performers include Anhui Wantuo Expressway (+18.66%), Jiangsu Ninghu Expressway (+14.71%), and COSCO Shipping Ports (+9.17%) [4][17]. - The report notes a low interest rate environment, with the 10-year government bond yield decreasing to 1.64% as of June 20, 2025, which supports the attractiveness of dividend assets [24]. - The report indicates a significant increase in average daily trading volume for ports, with a 213% year-on-year increase in June 2025 [25]. Monthly Market Performance - H-shares showed better performance compared to A-shares, with the transportation sector experiencing a cumulative decline of 0.80% from June 1 to June 20, 2025, underperforming the CSI 300 index by 0.96 percentage points [8][9]. - The report details that from June 1 to June 20, 2025, the cumulative performance of expressways, railways, and ports was -2.56%, -1.81%, and -1.01%, respectively, indicating a relative underperformance against the broader market [9][10]. Industry Data - In the expressway sector, passenger traffic in April 2025 reached 970 million, a year-on-year increase of 2.5%, while freight volume was 3.746 billion tons, up 4.1% year-on-year [35]. - The railway sector saw a passenger volume of 406 million in May 2025, reflecting a 12.6% year-on-year increase, while freight volume was 440 million tons, a 0.6% increase [51]. - Port throughput for monitored ports reached 1.054 billion tons in the four weeks from May 19 to June 15, 2025, marking a 2.2% year-on-year growth [58]. Investment Recommendations - The report suggests a continued positive outlook for transportation dividend assets, particularly in the expressway sector, where it recommends focusing on companies like Sichuan Chengyu Expressway and Anhui Wantuo Expressway due to their high dividend yields and stable growth potential [76][78]. - In the port sector, the report recommends companies like China Merchants Port, highlighting their overseas asset layout and potential for increased dividend payouts [79][80]. - For the railway sector, the report emphasizes the long-term value and reform benefits, recommending key assets like Beijing-Shanghai High-Speed Railway and Datong-Qinhuangdao Railway [78].